A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

Conditions:   Nasopharyngeal Carcinoma;   Neoadjuvant Chemotherapy Interventions:   Drug: 4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy;   Drug: 3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials